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Severe periodontitis is more common in HIV- infected patients  
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Introduction 
Periodontitis is an inflammatory disease of the tissues supporting the teeth caused by specific 
microorganisms or groups of specific microorganisms. This inflammation results in a 
progressive destruction of the periodontal ligament and alveolar bone with periodontal pocket 
formation, gingival recession or both 1. The prevalence of chronic periodontitis in the general 
population is approximately 30%. Severe generalized periodontitis is present in 5-15% of the 
population worldwide and is considered a major cause of tooth loss 2-4. Moreover, periodontitis 
is linked to an increased risk of age-related diseases, such as cardiovascular diseases, auto-
immune diseases and diabetes mellitus 5. 
Periodontitis is strongly associated with human immunodeficiency virus (HIV) infection 6-8. 
Patients with HIV infection who already have periodontitis appear to have a higher risk of 
aggravation of their periodontitis 9-11. The exact role of HIV infection in the progression of 
periodontitis is, however, not yet clear 10,11. HIV infected patients are also at higher risk of 
developing age-related diseases 12. It is unknown whether an interaction between HIV infection 
and periodontitis increases this risk.  
Prevalence of periodontitis in HIV infected patients before the introduction of combination 
antiretroviral therapy (cART) ranges from 51% in a British study to 62% in a study in the USA 
13,14. After the introduction of cART, the reported prevalence of periodontitis in HIV infected 
patients varied even more widely. For instance, in a study in India among 130 HIV infected 
patients, a prevalence of periodontitis of 20% was found 15 while a very small study (n=29) in 
Brazil reported a prevalence of 86% 16. This variation can be explained by the different 
definitions used in the studies 17,18, differences in social and economic status 19 as well as the 
availability of dental care and oral care awareness and the attitudes of dental practitioners 20. 
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Nowadays, HIV infection has become a chronic disease with a nearly normal life expectancy 21. 
Mortality of HIV infected patients mainly results from non-HIV associated age-related diseases. 
Therefore, the emphasis of HIV treatment and management has shifted towards prevention of 
cardiovascular disease and lifestyle interventions and includes early initiation of cART regimens 
with the fewest metabolic adverse effects 22. Data on the current prevalence and severity of 
periodontitis in HIV infected patients in resource-rich settings is lacking. As dental care is 
currently not an integrated part of HIV treatment, knowledge on the prevalence of periodontitis, 
its sequelae (tooth loss, and potential induction of cardiovascular disease) and modifiable risk 
factors could have a significant impact on oral and overall health of HIV infected patients. 
Therefore, the primary aim of this study was to assess the prevalence and severity of 
periodontitis in a representative sample of the HIV-infected population of the Netherlands, 
treated with cART, as compared to a control group from the same area. The secondary aim was 
to analyze whether patient characteristics, i.e. HIV infection characteristics, presence of age-
related diseases,  and oral health care characteristics, were associated with the severity of the 




Patients and Methods  
Patients 
Consecutive HIV infected patients were recruited at our outpatient clinic, at the University 
Medical Center, Groningen, the Netherlands between May and December 2015. Inclusion 
criteria for patients with HIV infection were ≥18 years of age and presence of ≥6 teeth. Exclusion 
criteria were history of radiation therapy in the head and neck region and inability to understand 
Dutch or English. The ethics committee of the University Medical Center Groningen (METc 
number 2014/128) approved this study.  
For comparison of the periodontal status of HIV-infected patients with that of historical controls, 
data from a previously described study were used 23. These historical controls (n=539) were 
patients randomly selected from a private dental practice located in the north of the Netherlands, 
the same geographic area where the HIV infected patients reside. 
 
Methods 
All included patients underwent a full-mouth periodontal examination by an experienced dental 
hygienist. Pocket probing depth was measured at six sites per tooth on all teeth with a manual 
periodontal probe (Williams probe 14 W, Hu-Friedy Mfg. Co., LLC, UK). Prevalence and severity 
of periodontitis were assessed using the Dutch Periodontal Screening Index (DPSI) 24 
comparable to the internationally used CPITN 25. Severity of periodontitis is measured by 
probing the depth of the crevice between the root and gum. Normally, this depth does not exceed 
3mm (DPSI or CPITN 0-2), a 4-5 mm probing pocket depth indicates mild periodontitis or 
gingivitis (DPSI or CPITN 3), while a depth of 6 mm or more indicates severe periodontitis (DPSI 
or CPITN 4). All included patients completed a health and oral care assessment questionnaire 
to identify additional medical conditions that might be associated with periodontitis, such as 
diabetes and cardiovascular diseases26-28. Age, ethnicity, body mass index (BMI), sex, and 
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smoking were recorded as potential determinants of periodontitis 29. Patients were also asked 
how often they visited their dentist and whether they had informed their dentist about their HIV 
infection. Furthermore, the oral health care habits of the patients were noted (e.g. brushing 
frequency, type of tooth brush, interdental cleaning, etc.).  
Data were collected from medical charts of patients with HIV infection regarding the mode of 
transmission, number of years with HIV infection, type of cART, current CD4+/CD8+ ratio, CD4+ 
nadir, viral load and Centers for Disease Control and Prevention (CDC) classification 30. Patients 
were classified as having ‘immune activation’ if the CD4+/CD8+ was ≤1.0 and as having ‘no 
immune activation’ if the CD4+/CD8+ was >1.0 31. CD4+ nadir (lowest CD4 ever recorded) was 
categorized as <200, 200-500, and ≥500 cells/mm3 30. Viral load measurement was performed 
on EDTA plasma samples using Abbott Real-Time HIV 1 assay and categorized as high (>1000 
copies/mL), low (>40-1000 copies/mL) or undetectable (≤40 copies/mL) 32,33. Patients were 
classified according to the ‘Revised Surveillance Case Definition for HIV Infection’ in three 
stages, according to the CD4+ T-lymphocyte count or presence of opportunistic illness 34. 
Data missing from the patient chart were completed by searching the database of the HIV 
monitoring Foundation (SHM), the national executive organization for registration and 
monitoring of consenting patients with HIV infection who are registered for care in the 27 HIV 




Differences between HIV infected patients and controls were analyzed using univariate analyses 
(independent sample t test or, χ2 test as appropriate). To statistically predict the risk of 
periodontitis in HIV infected patients and control group, a logistic regression analysis was 
performed with HIV (HIV infected=1), sex (male=1), age in years, diabetes (1=present), 
cardiovascular disease (1=present) and smoking (1=yes), as potential risk factors. All risk 
factors were entered in the regression model and removed if the significance of the regression 
coefficient was >0.10. Thereafter, interaction terms were explored. Within the group of HIV 
infected patients, potential risk factors of severity of periodontitis (age, sex, body mass index 
(BMI), smoking, plaque score, number of teeth, ethnicity, and other medical conditions, mode 
of HIV transmission, years of HIV infection and type of cART medication) were tested for 
significance using univariate analyses. Statistical analysis was performed with IBM SPSS 





Of the 731 patients registered with HIV 1 infection at our outpatient clinic, 471 patients visited 
the clinic between May and December 2015 for a routine appointment. Of these 471 patients, a 
total of 258 patients were included (Figure 1;Table 1; Table 2). No significant differences in 
gender, age, smoking, prevalence of diabetes and cardiovascular diseases were detected 
between the group of patients with HIV infection included in this study and the group of all 
registered HIV patients of the Department. Thus, the included group of patients with HIV 
infection was a representative subgroup of all registered 731 registered patients with HIV in 
Groningen (Table 3).   
 
Prevalence of periodontitis 
Prevalence of severe periodontitis was higher in HIV infected patients as compared to controls 
(pocket depth ≥6mm, which is compatible with DPSI 4: 64.7% versus 35.8.%; p<0.001; Table 
4). When patients with HIV infection were classified according to DPSI score, 34% of them had 
DPSI 3 and 66% of them DPSI 4. Logistic regression analysis revealed that HIV infection, age, 
gender and the interaction term age x age were significant risk factors for periodontitis, i.e., HIV 
infected patients had a higher risk for severe periodontitis than controls; older patients had 
higher risk for severe periodontitis until the age of approximately 55; thereafter the risk declined 
(Table 5). Male patients had a higher risk of developing severe periodontitis than female patients 
(Table 5). Other interaction terms were not significantly associated with periodontitis. Based on 
the regression outcomes, the risk for periodontitis was calculated (Figure 2): in all groups, the 
risk of having periodontitis gradually increased until the age of approximately 55 and declined 






cART, clinical, immunological and virological characteristics 
Clinical, immunological and virologic characteristics as well as type of cART were not associated 
with DPSI scores (Table 6). The number of smoking units per day was significantly higher in HIV 
infected patients with DPSI 4 compared to those with DPSI 3 (4.9 vs 2.0 smoking units/day, 
p<0.05.) 
 
Oral healthcare routine 
When HIV infected patients were classified according to DPSI score, the frequency of tooth 
brushing and use of interdental cleaning did not differ significantly between them. The 
questionnaire results showed that 44% of the patients did not inform their dentist about their HIV 
infection. Disclosure of HIV infection to the dentist was, however, not associated with DPSI score 
(Table 7). All patients, independently of their DPSI score, rated the importance of their dental 






In our study the prevalence of severe periodontitis in patients with HIV infection was 66%, almost 
twice as high as in uninfected controls. Our results are in line with the prevalence of severe 
periodontitis found in HIV-infected patients in London, United Kingdom in the pre-cART era: 
60% compared to 29% in controls 13. In a more recent German study, however, the prevalence 
of severe periodontitis in HIV infected patients was considerably lower, i.e. 30% 18, although the 
latter study did not specify any definition of severe periodontitis, making it impossible to compare 
both results. Moreover, with the exception of the aforementioned study by Robinson et al. 13, 
none of the studies included a comparable control group, hampering any conclusions on 
periodontitis prevalence and severity in HIV patients as compared to controls. 
Gender, age, the interaction term age x age and HIV infection, were the risk factors of severe 
periodontitis in the statistical analysis. Interestingly, we detected that the risk of severe 
periodontitis increased till the age of approximately 55 years and declined thereafter. This trend 
is in contrast to the general perception that the prevalence of severe periodontitis continuously 
increases with age 36. As age increases, teeth may be lost due to severe periodontitis, thus 
masking an increasing prevalence of severe periodontitis with age 37. Moreover, with increasing 
age, dentists may be more prone to remove teeth affected by severe periodontitis. As tooth loss 
in elderly patients is often considered a natural process, this shift in attitude towards extraction 
of teeth may also mask an increasing prevalence of periodontitis with age. Another explanation 
might be that the statistical model used in our study did not precisely estimate the risk of severe 
periodontitis in older ages due to the limited number of participants older than 65. 
HIV-infected men appear to have a higher risk of developing severe periodontitis than HIV-
infected women. This finding is in accordance with a previous study in HIV infected patients in 
Brazil where the prevalence of periodontitis was 30% for men and 20% for women 19. In general 
the cause of gender differences in the prevalence of periodontitis is not fully understood. It is 
postulated that oral hygiene level in males is poorer than in females or that hormonal, 
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physiological and behavioral differences, for instance more males smoke than females, may 
play a role 2,38. Interestingly, we found that HIV-infected women had the same prevalence of 
severe periodontitis as male HIV-uninfected controls. 
Our study shows that HIV-infected patients rate the importance of their oral health as very high, 
but many HIV infected patients do not inform their dentists about HIV infection. This failure to 
inform their dentist could be due to several factors. Fear of refusal of dental treatment or fear of 
stigmatization are probably the most common reasons for not disclosing HIV infection 20. Indeed, 
dentists’ concerns regarding increased personal risk is the most frequently reported reason for 
their reluctance to treat HIV-infected patients 39. Increased awareness of healthcare 
professionals about the higher prevalence of periodontitis in HIV-infected patients and could 
significantly improve oral health and thus the quality of life of HIV-infected patients. 
Patients with HIV infection are known to have a significantly higher prevalence of age-associated 
diseases, like hypertension, diabetes mellitus, obstructive pulmonary disease and renal 
dysfunction 40. It is postulated that the increased prevalence of cardiovascular diseases in HIV 
patients is due to activation of the immune system. Specifically, macrophages and monocytes 
activation, which play a significant role in atherogenesis, in combination with deregulation of 
CD8+ T-cells, are associated with higher values of carotid intimal media thickness and arterial 
stiffness 41 Likewise, HIV and periodontitis could interact and promote development of age-
associated diseases 23,42. We could not confirm that diabetes and cardiovascular diseases were 
significant risk factors for periodontitis in our HIV-infected patients, however. Further exploration 
of the relationship between periodontitis and HIV-related immune activation as a prognostic 
determinant of age-associated diseases is desirable. 
Smoking is strongly and consistently associated with periodontitis in the general population 43 In 
our study we detected a similar pattern in patients with HIV infection: smokers had a higher 
DPSI score compared to non-smokers. The exact cause of smoking as a risk factor for 
periodontitis in the general population is still unclear. Smoke components may impair the innate 
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immune system against pathogens, alter antigen presentation and modulate the adaptive 
immune response 44,45. In other studies periodontitis was also more prevalent in smoking 
compared to non-smoking HIV-infected patients 16,19. 
Finally, in our study we found no association between oral care characteristics, BMI, mode of 
HIV transmission, years of infection and type of cART with severity of periodontitis (DPSI 4). 
This lack of association could be attributed to the use of DPSI. DPSI can categorize patients 
into 3 groups: patients without periodontitis, with mild or with severe periodontitis, but does not 
quantify the severity of periodontitis in more detail. Future studies quantifying the severity of 
periodontitis as a continuous variable should shed more light on these issues.  
The major strength of our study is the complete and refined data collection for all patients, i.e., 
thorough medical history recording and detailed documentation of oral health characteristics, as 
well as comprehensive registration of immunological and virologic values. Additionally, the 
broad inclusion of patients may allow the generalization of our findings in similar Western 
European populations. Limitations, however, also apply. In the group of HIV infected patients, 
DPSI was applied to score presence of severe periodontitis (DPSI≥ 3+), while in controls 
presence of severe periodontitis was based on presence of pocket depths ≥6mm after full mouth 
periodontal probing. Since DPSI≥ 3+ corresponds to presence of pocket depths ≥6mm, we 
considered that the applied cut-off values (DPSI≥ 3+ and pocket depth ≥6mm) for presence of 
severe periodontitis are comparable. In our group of HIV infected patients 85% is male, which 
is in agreement with the gender distribution of HIV infected patients in Groningen and the 
Netherlands (81% male, table 3)46. Furthermore, we applied  questionnaires to assess the 
presence of general health issues instead of specific blood tests for underlying diseases as, 
e.g., diabetes mellitus. Consequently, patients might not have reported a disease, either 
because they did not mention it or were not aware of it yet, which may have resulted in 
underestimation of prevalence of health issues in our patient and control cohort. Additionally, 
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we did not specify the type of cardiovascular diseases, but we only registered their presence. 




Prevalence and severity of periodontitis are higher in patients with HIV infection as compared 
to controls, particularly in older males. Awareness of the increased prevalence of periodontitis 
associated with HIV infection among patients and health-care professionals could significantly 
improve oral health and thereby the quality of life of HIV-infected patients. 
Therefore, in order to preserve oral health and high quality of life, HIV patients should be 
routinely referred to oral health specialists by their treating physicians. 
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Figure 2: Risk for periodontitis in HIV-infected patients and controls based on the results of 
the logistic regression analysis. 
 




Table 1: Patient and dental  related characteristics of the 258 patients with HIV-1 infection. 
 Mean (SD) 
Age (years) 48.2 (11.0) 
Weight (kg) 78.7 (12.7) 
Height (cm) 179.6 (9.3) 
BMI male* 23.9 (3.2) 
BMI female 27.1 (5.6) 
  N (%) 
 Gender Male 219 (84.9) 
 Diabetes Yes 14 (5.4) 
Cardiovascular diseases absent 184 (79.7) 
present 47 (20.3) 
unknown 27 (10.5) 
Tobacco use Yes 93 (36.0) 
No 95 (36.8) 
Former smokers 70 (27.1) 
Ethnicity Africa 35 (13.6) 
Antarctica 0 
Asia 2 (0.8) 
Europe 209 (81.0) 
North America 10 (3.9) 
Australia 0 (0) 
South America 2 (0.8) 
The patient visits the dentist No 28 (10.9) 
Yes 195 (75.6) 
Yes, only in case of problems 35 (13.6) 
The dentist is informed about the HIV/AIDS infection** No 102 (44.3) 
DPSI  DPSI 0 0 (0) 
DPSI 1 0 (0) 
DPSI 2 1 (0.39) 
DPSI 3- 48 (18.6) 
DPSI 3+ 40 (15.5) 
DPSI 4 169 (65.5) 
*BMI  (Body Mass Index) was a significant different between male and female patients with HIV-1 infection (P<0.05)    ** in case 
of the 229 patients who visit the dentist ;1 answer was missing 
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Table 2: HIV related characteristics of the 258 patients with HIV-1 infection. 






 N (%) 
Mode of HIV transmission Homosexual sex 162 (62.8) 
Heterosexual sex 65 (25.2) 
Bisexual sex 14 (5.4) 
Blood transfusion or unknown 17 (6.6) 
Type of cART No medication 5 (1.9) 
PI-based 79 (30.6) 
NNRT-based 111 (43.0) 
INI-based 45 (17.4) 
Other 18 (7.0) 
Viral load Undetectable 224 (86.8) 
Low Level 19 (7.4) 
High Level 15 (5.8) 
CD4+ nadir <200*** cells/mm3 99 (38.4) 
200-<500 cells/mm3 119 (46.1) 
>500 cells/mm3 32 (12.4) 
CD4/CD8 immune activation  167 (64.7) 
No immune activation 91 (35.3) 
CDC classification Stage 1 32 (12.4) 
Stage 2 107 (41.5) 
Stage 3 119(46.1) 
 Median (IQR) 
CD4+ (cells/mm3) 610.0 [440.0;760.0] 
CD4+/CD8+ 0.8 [0.6;1.1] 
CD4+ nadir (cells/mm3) * 230.0 [110.0;330.0] 
Duration of infection  (years) 8.5   [4.7;13.4] 
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Table 3: Comparison of patients with HIV-1 infection included in this study with the group of registered patients at 
the Department of Infectious Diseases of the University Medical Center Groningen, Groningen, the Netherlands. 
 HIV-1-infected 
patients 
included in this 
study 
All registered 
patients with HIV-1 
infection in 
Groningen 
Number 258 731 
Male (N, %) 219 (85) 592 (81) 
Age (years, %) 18-≤24 5 (1.9) 11 (1.5) 
25≤34 23 (8.9) 76 (10.4) 
35≤44 69 (26.7) 154 (21.1) 
45≤54 92 (35.7) 226 (30.9) 
55≤65 48 (18.6) 169 (23.1) 
>65 21 (8.1) 79 (10.8) 
Smoking (N, %) Yes 93 (36.0) 192 (30.1) 
No 95 (36.8) 291 (45.7) 
Former smoker 70 (27.1) 154 (24.2) 
Diabetes  (%) 14 (5.4) 85 (11.6) 




Table 4: Characteristics of  in the HIV-infected patients and the controls.  
Characteristics HIV infected 
Patients (n=258) 
Controls (n=539) P Value 
Male N (%) 219 (85) 256 (47.5) <0.001 
Age Mean  (sd) 48.2 (11.0) 36.4 (12.1) <0.001# 
Periodontitis N (%)$  167(64.7) 193(35.8) <0.001 
Smoking N  (%) 163 (63.2) 80  (30)* <0.001 
Diabetes N (%) 14 (5.4) 17 (3.2)** 0.169 
Cardiovascular diseases N (%) 47 (20.3) 13 (2.4)*** <0.001 
#   95% conference interval:10.0-13.5, results of t-test for independent samples, all other results were derived from 
Chi-square test 
$ pocket depth ≥6 and/or DPSI 
*    data available in 268 patients 
**   data available in 558 patients 
*** data available in 512 patients 
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Table 5: Results of logistic regression analysis to predict periodontitis in HIV-infected groups and controls based on 
gender age and HIV infection.  
  
 
B S.E. Sig. Exp(B) 
95% C.I. for 
EXP(B) 
Lower Upper 
Gender 0.499 0.170 0.003 1.647 1.181 2.296 
 Age  0.228 0.039 <0.001 1.256 1.164 1.356 
 HIV-infected 0.487 0.185 0.008 1.627 1.133 2.336 
 Age x Age -0.002 0.0004 <0.001 0.998 0.997 0.999 
 Constant -6.183 0.844 <0.001 0.002     
Reference groups are females and controls 
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Table 6: Characteristics of patients with HIV-1 infection, classified according to DPSI* (the one patient with DPSI 2 is not shown).  
 DPSI 3- DPSI 3+ DPSI 4 P value 
Total, N (%) 48 (18.6) 40 (15.5) 169 (65.5)  
Male, N  (%) 39 (81.3) 32 (80.0) 148 (87.6) 0.350 
Age,  mean (SD) 44.4(13.2) 49.6(11.0) 48.9(10.1)) 0.028 
BMI, mean (SD)  24.4(3.1) 24.3(3.9) 24.5(4.0) 0.981 
Diabetes, N (%) No 45(93.8) 37(92.5) 162(95.9) 0.636 
Yes 3 (6.3) 3 (7.5) 7 (4.1) 
Cardiovascular diseases, N (%) No 36 (81.8) 28 (75.7) 120 (80.5) 0.787 
Yes 8 (18.2) 9 (24.3) 29 (19.5) 
Use of tobacco,   N (%) No 26 (54.2) 9 (22.5) 59 (34.9) 0.022 
Yes 10 (20.8) 17 (42.5) 66 (39.1) 
Former-smoker 12 (25.0) 14 (35.0) 44 (26.0) 
CDC classification, N (%)  Stage 1 5 (10.4) 5(12.5) 22(13.0) 0.766 
Stage 2 24 (20.0) 17(42.5) 66 (39.1) 
Stage 3 19 (39.6) 18 (45.0) 81(47.9) 
CD4/CD8  immune activation  33(68.8) 24(60.0) 109(64.5) 0.692 
No immune 
 
15(31.1) 16(40.0) 60(35.5) 
CD4+ nadir (%)  <200 cells/mm3 17 (35.4) 13 (36.1) 68 (41.2) 0.888 
200-500 cells/mm3 25 (52.1) 17 (47.2) 77 (46.7) 
≥500 cells/mm3 6 (12.5) 6 (16.7) 20 (12.1) 
Viral Load (%) Undetectable 42 (87.5) 35 (87.5) 146 (86.4) 0.943 
<1000  copies/mL 4 (8.3) 2 (5.0) 13 (7.7) 
≥ 1000  copies/mL 2 (4.2) 3 (7.5) 10 (5.9) 
 Type of cART, N (%) No medication 1(2.1) 0(0.0) 4(2.4) 0.254 
PI-based 17 (35.4) 16 (40.0) 45 (26.6) 
NNRT-based 22 (45.8) 14 (35.0) 75 (44.4) 
INI-based 8(16.7) 5 (12.5) 32 (18.9) 
Other 0 (0.0) 5 (12.5) 13 (7.7) 
Mode of transmission MSM 33(68.8) 25(62.5) 118(69.8) 0.373 
Heterosexual 14(29.2) 10(25.0) 40(23.7) 
Blood & otherwise 1(2.1) 5(12.5) 11(6.5) 




Table 7: Dental care characteristics of patients with HIV-1infection classified according to DPSI* (the one patient with DPSI 2 is 
not shown). 







Patient reported importance of dental 
health (VAS)Med  (IQR) 
 9(8-10) 9(8-10) 9(8-10) 0.776 
The patient visits the patient regularly 
(%) 
Yes  34 (70.8) 33 (82.5) 127 (75.1) 0.289 
Yes, only in 
case of 
problems 
5(10.4)- 4 (10.0) 26 (15.4) 
No  9 (18.8) 3 (7.5) 16 (9.5) 
The dentist is aware of the HIV-
infection (%) ** 
Yes  22 (56.4) 21 (56.8) 83 (54.6) 0.883 
No 17 (43.6) 16 (43.2) 69 (45.4) 
Periodontal treatment in the past (%) Yes  14 (29.2) 17(42.5) 78 (46.2) 0.110 
No  34 (70.8) 23 (57.5) 91 (53.8) 
Frequency of tooth brushing (%) Not daily  1(2.1) 0 (0.0) 7 (4.2) 0.803 
Daily  9 (18.8) 8 (20.0) 38 (22.8) 
Twice per day  31 (64.6) 28 (70.0) 103 (61.7) 
More than 
twice per day  
7 (14.6) 4 (10.0) 19 (11.4) 
Type of tooth brush (%) Electric  11 (25.0) 11 (31.4) 61 (18.4) 0.194 
Manual  27 (61.4) 20 (57.1) 68(43.0) 
Both  6 (13.6) 4 (11.4) 29 (18.4) 
Interdental cleaning(%) Yes  37 (77.1) 37 (92.5) 141 (83.4) 0.153 
No  11 (22.9) 3 (7.5) 28 (16.6) 
Full and/or partial dentures (%) Yes  5 (10.4) 5 (12.5) 23(13.6) 0.892 
No  43 (89.6) 35 (87.5) 146 (86.4) 
*Differences in DPSI were tested with Pearson Chi square test or one-way ANOVA  
 ** This question was applicable only for patients who stated to visit a dentist 
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